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Abstract
Mitochondria play a central role in ATP production and energy metabolism. Previous studies suggest that common variants
in mtDNA are associated with several common complex diseases, including obesity. To test the hypothesis that common
mtDNA variants influence obesity-related phenotypes, including BMI and body fat mass, we genotyped a total of 445
mtSNPs across the whole mitochondrial genome in a large sample of 2,286 unrelated Caucasian subjects. 72 of these 445
mtSNPs passed quality control criteria, and were used for subsequent analyses. We also classified all subjects into nine
common European haplogroups. Association analyses were conducted for both BMI and body fat mass with single mtSNPs
and mtDNA haplogroups. Two mtSNPs, mt4823 and mt8873 were detected to be significantly associated with body fat mass,
with adjusted P values of 4.94610
-3 and 4.58610
-2, respectively. The minor alleles mt4823 C and mt8873 A were associated
with reduced fat mass values and the effect size (b) was estimated to be 3.52 and 3.18, respectively. These two mtSNPs also
achieved nominally significant levels for association with BMI. For haplogroup analyses, we found that haplogroup X was
strongly associated with both BMI (adjusted P=8.31610
-3) and body fat mass (adjusted P=5.67610
-4) Subjects classified as
haplogroup X had lower BMI and fat mass values, with the b estimated to be 2.86 and 6.03, respectively. Our findings
suggest that common variants in mitochondria might play a role in variations of body fat mass. Further molecular and
functional studies will be needed to clarify the potential mechanism.
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Introduction
All nucleated cells contain mitochondria, organelles whose most
conspicuous roles are to produce ATP through respiration, and to
regulate cellular and energy metabolism [1]. Interestingly,
mitochondria are the only organelles of human cells, besides the
nucleus, that contain their own DNA (mtDNA). Human mtDNA
is a 16,569-bp, double-stranded circular molecule that contains 37
genes, and recent studies have demonstrated a relationship
between mtDNA variants and several human complex diseases.
Specifically, common variants in mtDNA have been shown to
contribute to a variety of neurological and metabolic diseases [1],
including diabetes [2,3], Alzheimer’s [4], and Parkinson’s [5]
disease.
Obesity is a common and highly heritable disease in humans
[6], whose prevalence has increased steadily in the US. If current
trends continue, it is anticipated that over 50% of American adults
will be obese by 2030, and that nearly 20% of total US health-care
expenditures will be directed to obesity-associated diseases [7].
Obesity can be viewed as a disease of energy imbalance in which
energy intake exceeds energy expenditure, resulting in excessive fat
storage [8]. Given the essential function of mitochondria in energy
metabolism, the potential contribution of mitochondrial dysfunc-
tion to cellular energy imbalances, metabolic disorders, and
obesity, has been the subject of several recent studies [9,10]. For
example, Pietila ¨inen et al. [9] found that mitochondrial energy
metabolism pathways were down-regulated in obese twins in a
study of 14 pairs of obesity discordant twins. Wortman et al. [10]
found a significant correlation between mitochondrial ATP
production and age-related body mass index (BMI) by researching
172 children investigated for a suspected disorder of oxidative
phosphorylation (OXPHOS). Moreover, recent population-based
association studies investigating the relationship between common
mtDNA variants and obesity found some nominally significant
signals [11], suggesting that genetic variants in mtDNA might play
an important role in susceptibility to obesity.
In this study, we performed genetic association tests to
systematically examine the relationship between common mtDNA
variants and obesity-related phenotypes, including body fat mass
and BMI. We genotyped a total of 445 mitochondrial single
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drial genome in a large sample of 2,286 unrelated Caucasian
subjects. Of these 445 mtSNPs, 72 passed quality control, and
these 72 mtSNPs were used to test for associations with BMI or
body fat mass. Furthermore, since human mtDNA usually exists in
haplogroup forms, we further classified subjects into nine common
European haplogroups previously defined by Torroni et al. [12],
based on specific mtSNPs throughout the mitochondrial genome.
We then conducted association analyses between these hap-
logroups and BMI or body fat mass.
Results
The basic characteristics of the study sample set are summarized
in Table 1. We first tested for associations between 72 mtSNPs and
BMI or body fat mass. We summarized the major association
results with BMI and body fat mass in Table 2. Data for 6 mtSNPs
are presented, five of which showed nominally significant levels
(P,0.05) of association with BMI (Table 2). However, none of
those remained significant after adjustment for multiple testing.
Five mtSNPs showed nominally significant levels (P,0.05) of
association with body fat mass (Table 2). After adjustment for
multiple testing, two mtSNPs, mt4823 and mt8873 were still
significant, with adjusted P values of 4.94610
-3 and 4.58610
-2,
respectively. The minor allele C of mt4823 and allele A of mt8873
were both associated with reduced fat mass values with the effect
size (b) estimated to be 3.52 and 3.18, respectively. These two
mtSNPs also achieved nominally significant levels of association
with BMI (Table 2). In order to validate our results, we randomly
split the total sample in half, and re-performed association tests
between mt4823 and mt8873 and body fat mass. These two
mtSNPs remained consistently significant in both random samples
(Sample 1: P=3.12610
-3 for mt4823, P=1.41610
-2 for mt8873;
Sample 2, P=7.46610
-3 for mt4823, P=4.05610
-2 for mt8873).
For haplogroup analyses, all nine common European hap-
logroups were observed in our sample (Table 3). 95.7% of subjects
belonged to these haplogroups, and the frequency of each
haplogroup was consistent with the findings of previous studies
of similar North American populations [5,12] (Table 4). After
association tests, one haplogroup (X) showed a strong signal with
BMI (adjusted P=8.31610
-3) and body fat mass (adjusted
P=5.67610
-4). Subjects classified as haplogroup X had signifi-
cantly lower BMI and fat mass values compared to subjects who
did not belong to haplogroup X, and the b was estimated to be
2.86 and 6.03, respectively. Considering the two significant SNPs
we identified (mt4823 and mt8873), we further re-constructed
haplogroup X including these two mtSNPs. The newly construct-
ed haplogroup X captured by mt4823, mt8873, mt7029, mt10399
and mt14471, was in high linkage disequilibrium (LD) with the
original haplogroup X (r
2 of 0.87). The newly constructed
haplogroup X was also significantly associated with BMI and
body fat mass, with adjusted P values of 1.02610
-2 and 8.51610
-4,
respectively. In order to validate our results we, again, randomly
split the total sample in half, and re-performed association tests
between haplotype X, body fat mass, and BMI. Results in the
divided sample were still significant for body fat mass (Sample 1:
P=2.56610
-3, Sample 2: P=9.65610
-3). For BMI, the P value
was significant in sample 1 (P=4.23610
-3), and marginally
significant in sample 2 (P=5.58610
-2).
Discussion
In the current study, in which we examined associations
between body fat mass or BMI with mtSNPs and mtDNA
haplogroups, we identified two mtSNPs, mt4823 and mt8873, that
were significantly associated with body fat mass after adjusting for
multiple testing. These two mtSNPs also achieved nominally
significant levels for association with BMI, but no significant
association was detected between mtSNPs and BMI after adjusting
for multiple testing. Our results also demonstrated that haplogroup
X was significantly associated with both with BMI and body fat
mass.
Our findings regarding BMI are largely consistent with the
results of Saxena et al. [11] who detected nominal signals of
association between BMI and specific mtSNPs in mitochondrial
genes, including ND1, ND2, ND3 and ATPase6; after adjusting for
multiple testing, these associations disappeared. Saxena et al. [11]
also found a nominally significant association between haplogroup
X and BMI (one-side P value is 0.049). Thus, the potential link
between haplogroup X and body fat mass is quite intriguing.
Although BMI is widely used as an index to identify overweight
individuals and define obesity due to its ease of measurement, BMI
cannot always distinguish obese people from large framed people.
Sometimes, genetic association tests might be underpowered to
detect obesity related genes using BMI independently. While using
both BMI and body fat mass as response variable one may observe
more interesting signals. This view was also supported by other
studies. For example, the CTNNBL1 gene was recently implicated
in the development of obesity in a genome-wide association study
using both BMI (most significant SNP: P=2.69610
-7) and body
fat mass (P=4.99610
-8) as obesity phenotypes [8,13]. However, if
BMI was investigated independently, the signal didn’t achieve the
genome-wide significance level (after multiple testing: P=0.06).
Therefore, BMI can be complemented by body fat mass, to
comprehensively characterize obesity status.
The mt8873 A/G SNP is a nonsynonymous SNP, that causes an
amino acid substitution of Phenylalanine (Phe) to leucine (Leu).
The mt8873 SNP is located in the ATPase6 gene (encodes ATP
synthase F0 subunit 6), which is essential for ATP synthase
function. ATPase6 is a key component of the proton channel, and
plays a direct role in the translocation of protons across the
mitochondrial membrane. Mutations in ATPase6 have been
implicated in several human diseases [14,15,16]. For example,
two children found to carry an inherited mutation in the ATPase6
gene suffered from mild encephalopathy, and became obese
following a period of normal postnatal growth [17]. Using
Escherichia coli as a model, Ogilvie et al. [18] found that missense
mutations in the ATPase6 gene can affect the ability of the enzyme
to pump protons and synthesize ATP. Therefore, the mechanism
by which mt8873 A/G affects obesity risk might be through
alterations in the function of ATP synthase.
Table 1. Basic characteristics of the study subjects.
Total sample
Number 2,286
Gender (Males/Females) 558/1,727
Age (years) 51.37 (13.76)
Weight (kg) 75.27 (17.54)
Height (cm) 166.35 (8.47)
BMI (kg/m
2) 27.14 (5.75)
Body fat mass (kg) 24.17 (10.63)
Note: Data are shown as mean (standard deviation, SD.).
doi:10.1371/journal.pone.0021595.t001
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(ND2), which is involved in the respiratory chain system and belongs to
complex I of the mitochondrion. The mt4823 C/A is a synonymous
change, which may act as a surrogate marker. The effect might be
mediated through nearby SNPs in LD with mt4823. An additional
explanation for the pathological mechanism of the mt4823 is that
mt4823C and mt4823A may differentially affect OXPHOS. However,
the potential mechanisms by which these SNPs impact obesity related
phenotypes must be confirmed through further functional analyses.
A potential limitation of our study is that our findings are still
unsubstantiated due to a lack of replication in other independent
large samples, especially for haplogroup X that has a low
frequency (0.01). However, we have cross-validated our results in
sub-samples established by randomly dividing our sample in half.
Additional support for our findings come from the study of Saxena
et al. [11], suggesting that our findings are certainly worthy of
follow-up. We intend to recruit additional subjects so that we can
perform replication analyses in an independent sample. Moreover,
we are hopeful that publication of our findings will facilitate
replication analyses by other groups.
In conclusion, we identified two mtSNPs (mt4823 and mt8873)
and mtDNA haplogroup X as markers that were significantly
associated with reduced body fat mass. Our findings suggested that
common variants in mitochondrial DNA play a role in variations
of body fat mass. Further studies are warranted to explore the
generality of our findings, and to determine the mechanisms
underlying the risk of obesity.
Materials and Methods
Study Subjects
The study was approved by the local institutional review boards
or the office of research administration of all participating
institutions. After signing an informed consent form, all subjects
completed a structured questionnaire addressing anthropometric
variables, lifestyles, and medical history. The sample contained
2286 unrelated adults, who were randomly identified from our
established and expanding database currently containing more
than 10,000 subjects. All of the chosen subjects were Caucasians of
Northern European origin living in the Midwestern US. They
were normal healthy subjects defined by a comprehensive suite of
exclusion criteria [19]. Briefly, subjects with chronic diseases and
conditions involving vital organs (heart, lung, liver, kidney and
brain) and severe endocrine, metabolic or nutritional diseases that
might affect fat metabolism were excluded from this study.
BMI was calculated as body weight (in kilograms) divided by the
square of height (in meters). Weight was measured in light indoor
clothing without shoes, using a calibrated balance beam scale, and
height was measured using a calibrated stadiometer. Body fat mass
was measured with Hologic 4500 DEXA machines. The short-
term reproducibility (coefficient of variation) of BMI and fat mass
measurements is on average 0.2 and 1.1%, respectively.
Measurement of body fat mass by DEXA is considered to be
highly accurate and gold standard. The correlation between BMI
and fat mass was 0.85 (P,0.01) in this sample.
Table 2. Major association results of mtDNA variants with BMI and body fat mass (P,0.05).
mtSNP Gene Alleles
Amino
change MAF PBMI Padjusted bBMI Pbody fat mass Padjusted
bbody fat
mass
mt4823 ND2 C/A Val -. Val 0.042 5.58610
-3 4.01610
-1 -1.36 6.86610
-5 4.94610
-3 -3.52
mt8873 ATPase6 A/G Phe -. Leu 0.029 6.32610
-3 1.51610
-1 -1.48 1.27610
-3 4.58610
-2 -3.18
mt16321 D-loop A/G --- 0.014 4.03610
-3 1.45610
-1 -2.90 4.13610
-3 9.91610
-2 -4.81
mt16141 D-loop C/T --- 0.027 1.39610
-2 2.51610
-1 -1.72 5.25610
-3 9.45610
-2 -3.29
mt12247 tRNA Ser C/G --- 0.035 2.46610
-1 1.00 -0.75 3.82610
-2 5.50610
-1 -2.10
mt11300 ND4 C/T Thr -. Thr 0.077 2.91610
-2 4.19610
-1 -0.92 1.34610
-1 7.45610
-1 -1.21
doi:10.1371/journal.pone.0021595.t002
Table 3. Classification of common European haplogroups.
Haplogroup C4217T C7029T A8252G G10399A C11720T G12309A A13709G C14471T G15219A T16393C
H --- C --- A --- --- --- --- --- ---
I --- T A G --- --- G --- --- ---
J --- T --- G --- --- A --- --- ---
K --- T --- G --- G G --- --- ---
T C T G A --- --- G --- --- ---
U --- T --- A --- G --- --- --- ---
V T T G A C --- --- --- A C
W --- T A A --- A G --- --- ---
X --- T --- A --- --- --- C --- ---
doi:10.1371/journal.pone.0021595.t003
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Genomic DNA was extracted from whole human blood using a
commercial isolation kit (Gentra systems, Minneapolis, MN, USA)
following the standard protocol. Genotyping was carried out using
the Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix,
Santa Clara, CA, USA), which includes 445 mtSNPs throughout the
mitochondrial genome, according to the Affymetrix protocol. Briefly,
approximately 250 ng of genomic DNA was digested with restriction
enzymeNspI and StyI. Digested DNA was adaptor-ligated and PCR-
amplified for each sample. Fragment PCR products were then
labeled with biotin, denatured, and hybridized to the arrays. Arrays
were then washed and stained using Phycoerythrin on Affymetrix
Fluidics Station, and scanned using the GeneChip Scanner 3000 7G
to quantitate fluorescence intensities. Data management and analyses
were conducted using the Genotyping Command Console. SNPs
were identified using Birdsuite (version 1.5.2; http://www.broad.mit.
edu/mpg/birdsuite/analysis.html).
In order to ensure high quality of the genotyping data, quality
control procedures were conducted as follows. First, only samples
with a minimum call rate of 95% were included. After repeated
experiments, all samples (n=2,286) met this criteria and the final
mean call rate reached a high level of 98.93%. We also excluded
individuals with hidden relatedness, which was generated from
identity-by-descent matrix file at pi_hat .0.15 using PLINK[20].
Eighty-three pairs of individuals showed possible relatedness with
pi_hat greater than 0.15. Thus, one of each pair was excluded
from the subsequent analyses. Second, out of the initial 445
mtSNPs, we discarded mtSNPs: 1) with a call rate ,95% (n=25);
2) with genotyping concordance rate ,95% (obtained by duplicate
samples, n=6); 3) with a minor allele frequency (MAF) ,0.01
(n=342; which was consistent with HapMap data in which 366 of
445 mtSNPs had a MAF less than 0.01). Because most mtSNPs
were observed as rare SNPs (MAF ,0.01) and were therefore
excluded, only 72 common mtSNPs passed our quality control for
subsequent analyses. The basic characteristics of these mtSNPs are
summarized in Table S1.
Statistical analyses
Before association analyses, principal component analysis
implemented in EIGENSTRAT [21] was used to correct for
potential population stratification that may lead to spurious
association results. The first ten principal components emerging
from the EIGENSTRAT analyses, along with sex, age and
smoking status were included in the multiple regression model to
tested for their correlations with BMI and fat mass. Significant
variables (P#0.05) were then included as covariates to adjust the
raw BMI and fat mass values. The residuals after adjustment were
used for association analyses.
Single-mtSNP Analysis. All association analyses were
conducted in R v.2.11. For single-mtSNP variants, Student’s t-
test model was used to assess the difference in subjects carrying
different mtSNP alleles. A raw P value of ,0.05 in our study was
considered nominally significant; this was further subjected to
Benjamini and Hochberg’s (BH) procedure [22] to account for
multiple comparisons. The effect size (b, regression coefficient) was
estimated by linear regression.
Haplogroup Analysis. According to the published
references and the Mitomap database [3,12,23], we selected 10
specific mtSNPs to define the most common European
haplogroups including H, I, J, K, T, U, V, W, and X (Table 3).
Genotypes of these 10 mtSNPs were combined to construct
mitochondrial haplogroups. Haplogroups that could not be
assigned to one of these nine major haplogroups by mtSNP
combinations were designated as ‘‘others’’. For haplogroup
association analyses, we determined the difference between
phenotypic characteristics of each individual haplogroup and all
other haplogroups pooled into one group. This is conceptually
the same as the binary SNP allele comparison, which was
accomplished by Student’s t-test model. The effect size (b)w a s
estimated by linear regression. Multiple testing was also adjusted
by BH procedure [22].
For the significant mtSNPs or haplogroups we identified, we
further split the total sample in half randomly, and re-performed
the association tests in those two random samples. This approach
enabled us to cross-validate our results, without having an
independent sample.
Supporting Information
Table S1 Properties of SNPs in mtDNA tested in this
study.
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Table 4. Association results of common European haplogroups with BMI and body fat mass.
Haplogroup PBMI Pajusted bBMI Pbody fat mass Pajusted bbody fat mass frequency
H 0.440 NS -0.203 0.533 NS -0.271 0.437
J 0.975 NS -0.093 0.876 NS 0.120 0.086
U 0.434 NS -0.307 0.608 NS -0.279 0.164
K 0.412 NS -0.484 0.984 NS -0.017 0.059
I 0.803 NS 0.086 0.572 NS 0.806 0.027
W 0.279 NS 0.904 0.222 NS 2.140 0.023
T 0.391 NS 0.206 0.625 NS 0.353 0.099
X 8.31610
-4 8.31610
-3 -2.856 5.67610
-5 5.67610
-4 -6.031 0.010
V 0.682 NS -0.289 0.625 NS -0.446 0.052
doi:10.1371/journal.pone.0021595.t004
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